Skip to NavigationSkip to content


New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.
GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.
GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with Pharmacia.
All NHS trusts will have to review how they report waiting times after a spot check found widespread distortion and fiddling of figures.
Bayer and GlaxoSmithKline's new erectile dysfunction treatment Levitra has been launched in the UK, its first market after receiving European...
A chronic shortage of staff in some parts of the NHS is holding back improvements to the service, according to a major new report.
Bristol-Myers Squibb is attempting to draw a line under allegations of fraud and financial misconduct by downgrading earnings as far back as 1999.
Continuing conflict over access to medicines in developing countries and growing distrust of big pharma in domestic markets is threatening to...
AstraZeneca's cholesterol treatment Crestor has been dealt a serious blow following Germany's withdrawal from a pan-European approval process.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches